Wallye Holloway

• Developed strategic offerings to enhance company's suite of products and services.
• Strengthened company business by leading implementation of new projects and account focused procedures.
• Expanded portfolio by 20% with new business win.
• Led the growth of additional agency offerings within current client businesses.

• Leader of the largest healthcare agency within Wunderman Thompson Health North America – agency team of 120, P&L responsibility of $41MM, diversified portfolio of healthcare and consumer/wellness brands.

Areas of focus and accomplishments:

• Revenue growth and portfolio expansion - $15MM
• Strong organizational leadership – Creative, Engagement Strategy, Operations Operational transformation – Implementation of core operational protocols
• Co-led the seamless unification of the healthcare and consumer agency teams into one Wunderman Thompson NY after the agency merger
• Heath Equity – Expert capabilities and credentials leading to business building initiatives - Health4Equity.
• Creative bravery - Finalist in eight categories for MM&M awards (as of 7-15-22) • Culture shaping – Establishment of agency vision

• Leader of a global multidisciplinary global team for a major oncology brand
• Built the operational protocols and procedures and codified the ways of working
• Staffed over 50 people in six months
• Led the team in the development of a team mission and culture
• Single point of contact for joint venture client structure
• Co-founder of #BlackHealthNow – Livestream platform focused on creating awareness of inequities in healthcare for underserved communities
• Co-leader of TBWA\WH DE&I initiative - Change Ambassadors

• Oversight of a multidisciplinary team focused on strategic and launch planning for the top immunotherapy oncology brand
• Responsible for cross-functional collaboration within a consolidated agency model
• Directed multiple successful launches for the largest brand indication
• Led account digital training for the Account department.

• Promoted to lead a multidisciplinary agency team of over 35 including, account, creative, digital strategy, project management
• Successfully oversaw agency growth with first-year revenue increase of 28%, and 8% growth from 2014 to 2015
• Oversaw the transition of the agency to independence with full P&L management responsibilities
• Developed and led effective teams, and fostered strong client relationships
• Effectively managed freelance budgets and directed freelance hiring across agency disciplines
• Directed the development of a unique cultural identity and vision for the organization (Science and Imagination)
• Executive oversight of the successful global launch of Amgen’s IMLYGIC; launch preparation for Acadia Pharmaceutical’s NUPLAZID; and the successful brand re-positioning campaign for Gilead’s RANEXA
• Developed strong working relationships with senior-level brand managers, as well as client procurement contacts
• Fostered the development of innovative, award-caliber work across digital and traditional media platforms –submission for awards for work on Acadia pharmaceuticals disease education campaigns in 2014 and 2015
• Oversaw creation of innovative and groundbreaking technologies in healthcare for key clients: Oculus Rift technology, and Leap Motion technology.

• Oversaw a team of over 20 as senior client lead in partnership with the Creative Director
• Spearheaded strategic business planning and promotion across traditional and digital platforms
• Led the pitch team for XIFAXAN, and directed the successful strategic re-positioning campaign, which led it to become the most important revenue-generating brand in the Salix (now Valeant) GI franchise
• Oversaw forecasting for the group portfolio and generated year-over-year revenue increases
• Led the XIFAXAN team in the development an award caliber documentary – Wresting the Monster, resulting in a 26% increase in awareness of the need for more adequate treatment
• Successful oversight and leadership, as well as strong client relationships led to the addition of three Salix brands, all without pitches – Fulyzaq, Solesta and Deflux
• Established strong relationships with Pfizer RBU clients, which led to a partnership with Quest Diagnostics
• Directed work streams for Quest Diagnostics
• Oversaw development of a campaign for the Quest Diagnostics vitamin D test, which made the Shortlist at Lions Health 2015 – Putting Vitamin D to the Test.

• Led a multi-disciplinary team of 15 across key business groups – Pfizer, Optimer and GroupThink
• Oversaw financial forecasting and revenue generation across the group
• Expertise with unique account business models led to the launch of a successful agency consultancy – GroupThink
• Directed a consultancy team of strategy, account, and creative team members
• Expanded the agency expertise in understanding and leveraging business opportunities in the new healthcare business landscape
• Led the pitch team for Optimer Pharmaceutical’s (now part of Merck’s Cubist Pharmaceuticals) – DIFICID
• Successfully launched DIFICID to infectious disease physicians in two months
• Responsible for an additional $2.5mil in new revenue across various brands in two years.

• Promoted to greater portfolio oversight
• Responsible for managing large multi-client portfolio — Pfizer and Gilead
• Oversaw account teams and led strategic and planning efforts for brand promotion across multi-channel platforms
• Selected to lead a pitch team for two key brands in the Gilead HIV franchise — TRUVADA and COMPLERA — for CDM Princeton
• Directed the successful global launch of COMPLERA, which included the European agency hub – CDM Barcelona
• Developed a new leadership team structure, which focused on client business planning initiatives – The Business Council
• Spearheaded successful implementation of business-building brand initiatives for key clients
• Led a winning pitch for Pfizer Regional Business Unit account
• Successfully expanded the RBU business from one to five regions in three years – an additional $2mil annually
• Responsible for RBU becoming a centerpiece in the CDM relationship with Pfizer.

• Successfully oversaw key brands for Novartis and Pfizer, while leading a new agency offering
• Created a new CDM offering, CultureVue resulting in two new Agency of Record assignments — Novartis Multicultural and Pfizer Multicultural
• Successful financial oversight resulted in $5mil in additional agency revenue.
• Led a successful pitch team for the Pfizer Zyvox account
• Responsible for overseeing the successful re-positioning campaign resulting in a 30% increase in brand uptake among hospital-based infectious disease physicians and Hospitalists

• Successful launch of ARANESP Oncology for Amgen
• Managed the launch team with an abbreviated timeline to market entry.